CANTONI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 11.006
Totale 11.006
Nazione #
IT - Italia 11.006
Totale 11.006
Città #
Genova 9.136
Rapallo 1.142
Genoa 708
Bordighera 20
Totale 11.006
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 185
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 161
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 160
Role of the calpain-calpastatin system in the density-dependent growth arrest 150
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 143
Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation. 140
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 136
Effect of tumor cells and tumor microenvironment on NK-cell function. 135
A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. 134
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 134
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 132
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 128
Expression and crystallographic characterization of the extracellular domain of human Natural Killer cell triggering receptor NKp46 128
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 127
Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a 126
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 125
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. 124
Induction of anti-tumor immune response by bispecific monoclonal antibodies (bimAbs). 123
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 123
A novel type of GABA receptor in rat spinal cord? 123
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 120
DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis 119
HLA class-I-specific NK receptors belong to two distinct molecular families and display inhibitory or activating function. 119
P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily. 119
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 118
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 118
Molecular structures of HLA-specific human NK cell receptors. 117
DNAM-1 and PVR regulate monocyte migration through endothelial junctions 116
Characterization of human afferent lymph dendritic cells from seroma fluids. 115
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 114
Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells 114
Physical and functional association of CD45 and CD3-TCR complex on CD1+ human thymocytes. Evidence that the engagement of CD45 molecules can prevent CD1+ thymocytes from apoptosis. 113
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 112
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. 112
Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cells. 112
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 112
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing 112
Human natural killer cell function and receptors. 110
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 110
Crystallization and preliminary crystallographic characterization of the extracellular Ig-like domain of human natural killer cell activating receptor NKp44 110
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 110
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 109
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 107
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 107
The three-dimensional structure of NK cell receptor NKp44, a triggering partner in natural cytotoxicity 106
Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity. 105
Identification of the rat homologue of the human NKp46 triggering receptor 105
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily 104
Human natural killer cell receptors: insights into their molecular function and structure 103
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 103
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 102
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 102
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 102
Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30 100
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 99
Crystal structure of the extracellular domain of the human natural killer cell activating receptor NKp44 98
Human natural killer cell receptors and co-receptors. 98
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. 97
Human NK cells and their receptors 95
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 95
Role of NK cells in immunotherapy and virotherapy of solid tumors 95
Phenotypic, functional and molecular analysis of CD3- LGL expansions indicates a relationship to two different CD3- normal counterparts. 95
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 95
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 94
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 94
The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function 93
Effect of Melanoma-derived Fibroblasts on NK Cell Phenotype and Functions 93
The three-dimensional structure of NK cell receptor NKp44, a triggering partner in natural cytotoxicity 93
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity 92
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 92
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 91
Human natural killer cell activating receptors. 91
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor 90
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. 89
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells 89
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 89
Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. 89
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 87
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 86
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. 85
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. 85
Structure of the human NK cell triggering receptor NKp46 ectodomain 84
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 84
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules. 81
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 81
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 80
Cultured human NK cells express the Ki-1/CD30 antigen. 80
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 80
The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or disfunction of triggering receptors involved in natural cytotoxicity. 79
Identification, molecular cloning and functional characterization of NKp46 and NKp30 Natural Cytotoxicity Receptors in Macaca fascicularis (Macaca Rhesus) NK cells 78
Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. 77
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. 76
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 76
Molecular and functional characterization of NKG2D, NKp80 and NKG2C triggering NK cell receptors in Rhesus and Cynomolgus macaques: monitoring of NK cell function during SIV/HIV infection 76
Natural killer cells in pregnancy: how they may avoid their attack to fetal tissues 75
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 75
MELANOMA CELLS INTERFERE WITH THE ACTIVITY OF NK CELLS BY MODULATING THEIR PHENOTYPE AND CYTOTOXIC FUNCTION 75
Human decidua contains NK cell committed CD34+ hematopoietic precursors able to differentiated into functional Natural Killer cells 73
The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. 72
Melanoma cells inhibit natural killer cell function by modulating their phenotype 72
Totale 10.457
Categoria #
all - tutte 27.645
article - articoli 26.462
book - libri 0
conference - conferenze 905
curatela - curatele 0
other - altro 0
patent - brevetti 249
selected - selezionate 0
volume - volumi 29
Totale 55.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019761 0 0 0 0 0 0 0 0 6 149 327 279
2019/20203.406 177 97 139 234 321 368 489 251 315 557 339 119
2020/2021979 57 113 108 83 45 95 48 78 83 101 91 77
2021/20221.419 59 111 132 170 60 75 75 334 54 121 68 160
2022/20231.365 126 81 14 145 205 244 2 162 207 8 154 17
2023/2024514 28 78 24 97 79 101 23 41 43 0 0 0
Totale 11.238